[BASI] Bioanalytical Systems, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Commercial Physical & Biological Resarch

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 0.88 Change: 0.09 (11.39%)
Ext. hours: Change: 0 (0%)

chart BASI

Refresh chart

Description: Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in North America, the Pacific Rim, Europe, and internationally. It operates in two segments, Contract Research Services and Research Products. The Contract Research Services segment offers various services, including product characterization, method development, and validation; bioanalytical testing to measure drug and metabolite concentrations in complex biological matrices; and stability testing to establish and confirm product purity, potency, and shelf life. It also provides in vivo sampling services for the continuous monitoring of chemical changes in life; and pharmacokinetic and safety testing services, as well as provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing services. The Research Products segment offers analytical produc

Fundamental Ratios
Shares Outstanding EPS-0.17 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -5.07% Sales Growth - Q/Q-2.04% P/E-9.35
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin31.27% Operating Margin-0.26% Net Profit Margin0.6% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-750 K Cash From Investing Activities-230 K Cash From Operating Activities440 K Gross Profit1.8 M
Net Profit150 K Operating Profit30 K Total Assets23.01 M Total Current Assets6.4 M
Total Current Liabilities8.75 M Total Debt5.27 M Total Liabilities13.02 M Total Revenue5.73 M
Technical Data
High 52 week2.02 Low 52 week1.22 Last close1.58 Last change5.33%
RSI62.38 Average true range0.09 Beta0.15 Volume18.46 K
Simple moving average 20 days10.89% Simple moving average 50 days16.17% Simple moving average 200 days2.53%
Performance Data
Performance Week15.33% Performance Month16.95% Performance Quart15.33% Performance Half-7.06%
Performance Year-3.66% Performance Year-to-date24.41% Volatility daily3.14% Volatility weekly7.02%
Volatility monthly14.38% Volatility yearly49.83% Relative Volume145.56% Average Volume14.3 K
New High New Low

News

2019-03-08 13:07:42 | Does Bioanalytical Systems, Inc. NASDAQ:BASI Have A Volatile Share Price?

2019-03-07 08:33:00 | J. Scott Daniels, PhD, Joins BASi as Senior Vice President of DMPK, Filling Key Scientific Leadership Position

2019-02-21 09:23:00 | BASi Appoints Joe Flynn as Chief Commercial Officer

2019-02-15 08:03:00 | BASi Appoints Senior Contract Research Executive, D. Thomas Oakley, as Chief Operating Officer

2019-02-14 08:03:00 | BASi Reports Revenue Growth in First Quarter of Fiscal 2019

2019-02-12 11:52:27 | Bioanalytical Systems to Release First Quarter Fiscal 2019 Results on Thursday, February 14, 2019

2019-01-16 08:33:00 | BASi Elects Entrepreneur, Who Has Led BASi Turnaround and Recent Growth, as President and Chief Executive Officer and a Director

2018-12-20 08:03:00 | BASi Continues Revenue Gains to Close Fiscal 2018

2018-12-18 14:03:00 | Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2018 Results on Thursday, December 20, 2018

2018-11-16 11:12:23 | Can Bioanalytical Systems Inc NASDAQ:BASI Improve Its Returns?

2018-11-01 08:43:00 | BASi Names John E. Sagartz Chief Strategy Officer

2018-10-17 08:33:00 | BASi Breaks Ground on Expansion of GLP Toxicology Facility in Indiana

2018-08-24 11:29:11 | How Has Bioanalytical Systems Inc’s NASDAQ:BASI Earnings Fared Against The Long Term Trend

2018-08-14 08:33:00 | BASi Reports Third Quarter Results with Revenue Gains

2018-08-08 08:33:00 | Bioanalytical Systems to Release Third Quarter Fiscal 2018 Results on Tuesday, August 14, 2018

2018-07-09 09:00:00 | BASi Announces Appointment of John E. Sagartz to Board of Directors

2018-07-02 09:00:00 | BASi and Seventh Wave Laboratories Combine Operations to Provide Broader Solutions and Greater Scientific Expertise to Clients

2018-06-27 10:43:45 | Does Bioanalytical Systems Inc’s NASDAQ:BASI PE Ratio Signal A Buying Opportunity?

2018-05-25 16:57:18 | With An ROE Of 6.16%, Has Bioanalytical Systems Inc’s NASDAQ:BASI Management Done Well?

2018-05-15 08:33:00 | BASi Reports Second Quarter Results

2018-05-10 08:33:00 | Bioanalytical Systems to Release Second Quarter Fiscal 2018 Results on Tuesday, May 15, 2018

2018-04-30 14:37:00 | James Bourdage to Retire as BASi VP of Bioanalytical Operations; Michael Baim Named as Successor

2018-04-04 08:25:00 | BASi and Phlebotics Form Strategic Alliance; Continuing a Commitment to Automated Blood Sampling

2018-03-27 08:15:00 | Bolstering Preclinical PK/PD Operations: BASi Hires Karen L. Rogers, DVM, DACLAM, CPIA as Attending Veterinarian

2018-03-08 12:03:30 | What Investors Should Know About Bioanalytical Systems Inc’s NASDAQ:BASI Financial Strength

2018-02-14 15:59:17 | Why Bioanalytical Systems Inc’s NASDAQ:BASI CEO Salary Matters To You

2018-02-13 07:00:00 | BASi Reports First Quarter Results

2018-02-12 11:36:23 | All You Need To Know About Bioanalytical Systems Inc’s NASDAQ:BASI Risks

2018-02-08 11:15:00 | Bioanalytical Systems to Release First Quarter Fiscal 2018 Results on Tuesday, February 13, 2018

2018-01-23 19:03:23 | Why Bioanalytical Systems Inc NASDAQ:BASI Delivered An Inferior ROE Compared To The Industry

2018-01-02 13:59:12 | Is Bioanalytical Systems Inc NASDAQ:BASI A Buy At Its Current PE Ratio?

2017-12-26 08:40:21 | Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q4, 2017 By the Numbers : December 26, 2017

2017-12-22 16:48:05 | Bioanalytical Systems Inc BASI Files 10-K for the Fiscal Year Ended on September 30, 2017

2017-12-19 08:35:00 | BASi Continues Profitability Improvement to Close Out Fiscal 2017

2017-12-15 14:00:00 | Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2017 Results on Tuesday, December 19, 2017

2017-12-12 08:33:00 | BASi Announces Enhanced Bioequivalence Capabilities

2017-11-21 09:59:08 | What Investors Should Know About Bioanalytical Systems Inc’s BASI Financial Strength

2017-11-13 08:33:00 | Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana

2017-10-03 08:17:00 | Gaining Momentum: BASi Adds Candace Rohde-Johnson as Director of in Vivo Products and Services

2017-09-22 13:06:12 | Bioanalytical Systems Inc BASI: Is Healthcare An Attractive Sector Play?

2017-09-06 08:17:00 | BASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion Technology

2017-08-22 07:00:00 | Featured Company News - Myriad Genetics' EndoPredict Receives Positive Coverage Decisions from Palmetto and Anthem

2017-08-16 12:10:53 | Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017

2017-08-14 08:30:00 | BASi Reports Continued Profitability Improvement in Third Quarter

2017-08-03 08:33:00 | BASi Announces Election of R. Matthew Neff to the Board of Directors

2017-07-31 08:03:00 | BASi Signs Reseller Agreement With LABEX of MA for Refurbished CulexR Automated Blood Sampling Systems

2017-06-27 09:00:00 | BASi Completes Refinancing of Senior Secured Credit Facilities

2017-06-07 10:09:00 | BASi Announces Validated _SEND_ Capabilities and Compliance With FDA's Standard for Exchange of Nonclinical Data

2017-05-24 09:50:22 | Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q2, 2017 By the Numbers : May 24, 2017

2017-05-15 08:30:00 | BASi Reports Second Quarter Results